Neuropharmacokinetic Heterogeneity of Mefloquine in the Treatment of Progressive Multifocal Leukoencephalopathy

Internal Medicine - Japan
doi 10.2169/internalmedicine.51.8079
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Progressive Multifocal Leukoencephalopathy

Journal of Multiple Sclerosis
2013English

Progressive Multifocal Leukoencephalopathy

Neurology
Neurology
2002English

Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7

JAMA Neurology
Neurology
2014English

Progressive Multifocal Leukoencephalopathy in the Absence of Immunosuppression

Journal of NeuroVirology
VirologyNeurologyCellularMolecular Neuroscience
2017English

Progressive Multifocal Leukoencephalopathy: Current Insights

Degenerative Neurological and Neuromuscular Disease
2019English

Cerebellar Form of Progressive Multifocal Leukoencephalopathy (PML)

Canadian Journal of Neurological Sciences
MedicineNeurology
1979English

Treatment-Related Progressive Multifocal Leukoencephalopathy: Current Understanding and Future Steps

Therapeutic Advances in Drug Safety
Pharmacology
2012English

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy

Case Reports in Infectious Diseases
2016English

Progressive Multifocal Leukoencephalopathy: Clinical and Molecular Aspects

Reviews in Medical Virology
VirologyInfectious Diseases
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy